Trial
NCT01505764
The Role of Ghrelin in Cancer Cachexia
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
VA Office of Research and Development
Collaborators
Helsinn Therapeutics (U.S.), Inc
Condition
Cancer Cachexia
Intervention
Anamorelin HCl
Why stopped
poor recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-17